Skip to main content
. 2020 Mar 27;135(24):2137–2145. doi: 10.1182/blood.2020004856

Figure 1.

Figure 1.

Overall survival. Kaplan-Meier plots showing OS rate of all patients over time, separated by treatment arm; patients at risk at each time point are shown below graph. Tick marks indicate censored data. (A) Preplanned OS analysis. (B) OS analysis with 6 months of additional follow-up. Pbo, placebo; Ven, venetoclax.